Please select the option that best describes you:

How would you approach the treatment of a patient with a history of cutaneous melanoma and only overt site of disease being a bulky level III axillary lymph node?  

Specifically, this patient was unable to tolerate immunotherapy due to severe side effects.



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more